Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study

Background Dialysis patients are at risk for lower SARS-CoV-2-vaccine immunogenicity than the normal population. We assessed immunogenicity to a first mRNA- or vector-based SARS-CoV-2-vaccination dose in dialysis patients. Methods In a multicenter observational pilot study, 2 weeks after a first vac...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of nephrology 2021-08, Vol.34 (4), p.975-983
Hauptverfasser:	Lesny, Paul, Anderson, Mark, Cloherty, Gavin, Stec, Michael, Haase-Fielitz, Anja, Haarhaus, Mathias, Santos, Carla, Lucas, Carlos, Macario, Fernando, Haase, Michael
Format:	Artikel
Sprache:	eng
Schlagworte:	BNT162 Vaccine ChAdOx1 nCoV-19 COVID-19 COVID-19 Vaccines Humans Medicine Medicine & Public Health Nephrology Pilot Projects Prospective Studies Renal Dialysis Research Letter RNA, Messenger SARS-CoV-2 Urology Vaccination
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!